Search Results

You are looking at 211 - 220 of 2,852 items for :

  • Refine by Access: All x
Clear All
Full access

Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone

Neal Andruska, Benjamin W. Fischer-Valuck, Ruben Carmona, Temitope Agabalogun, Randall J. Brenneman, Hiram A. Gay, Jeff M. Michalski, and Brian C. Baumann

BT + ADT Relative to EBRT Alone Given the significant potential selection bias for EBRT versus BT, IPTW was used to balance covariables that influenced both treatment allocation and outcomes, and weight-adjusted Cox regression was used to

Full access

Randomized Trial of a Supportive Psychotherapy for Parents of Adolescents and Young Adults With Hematologic Malignancies

Michael Koehler, Susanne Hoppe, Siegfried Kropf, Anke Lux, Rainer Bartsch, Bernhard Holzner, Juergen Krauter, Axel Florschütz, Kathleen Jentsch-Ullrich, Joerg Frommer, Hans-Henning Flechtner, and Thomas Fischer

personal accountability, maladaptive coping and numerous time-consuming demands may negatively affect their own physical and mental health, and this in turn may negatively affect the health outcomes of AYA patients. 2 – 7 , 16 – 20 , 29 , 30 Parents’ self

Full access

HSR24-148: Outcome of Positron Emission Tomography–Computed Tomography Staging in Breast Cancer Patients Having Neo-Adjuvant Systemic Therapy

Raouef Ahmed Bichoo, Mohammed Bilal Elahi, Naila Bint Ihsan, Dorin Dumitru, Brendan Wooler, Peter Kneeshaw, MB ChB, and Kartikae Grover

Background: NCCN guidelines recommend staging investigations should be part of the work up for breast cancer patients having preoperative systemic therapy. We aim to determine the outcome of PET CT staging performed in patients receiving neo

Full access

HSR21-076: Valued Outcomes in the Cancer Experience (VOICE™): Developing and Validating a Measure of Patient Experience

Alexandra K. Zaleta, Erica E. Fortune, Melissa F. Miller, Branlyn W. DeRosa, Joanne S. Buzaglo, Karen Hurley, Mitch Golant, Sara Goldberger, Bruce Rapkin, Lillie D. Shockney, Jemeille Ackourey, and Kelly A. Clark

Background: Despite recognition that patient perspectives should inform cancer care, validated measures that meaningfully capture the patient experience across the cancer continuum remain lacking. We developed Valued Outcomes in the Cancer

Full access

HSR20-081: The Direct Referral Unit: Clinical Outcomes and Experience With a Specialized Urgent Care Center for Oncology Patients

Christopher D'Avella, Peter Whooley, Emily Milano, Brian Egleston, Martin Edelman, James Helstrom, Kenneth Patrick, and Jessica Bauman

admissions. Fox Chase Cancer Center (FCCC) developed an urgent care center, the direct referral unit (DRU), in 2012. We sought to characterize the experience of the DRU and its impact on clinical outcomes and utilization. Methods: We abstracted data for

Full access

HSR20-094: Treatment Patterns, Healthcare Resource Utilization and Patient-Reported Outcomes for Patients Diagnosed With Small Cell Lung Cancer

Junji Lin, Santosh Gautam, Nan Hu, Debra Wertz, Gboyega Adeboyeje, and Sumesh Kachroo

) and patient-reported outcomes (PROs). This study describes patient characteristics, treatment patterns, HCRU and PROs for these pts in community oncology settings. Methods: Retrospective medical records data from adults diagnosed with eSCLC between 1

Full access

Introduction to the Cancer Center Cessation Initiative Working Groups: Improving Oncology Care and Outcomes by Including Tobacco Treatment

The Cancer Center Cessation Initiative Coordinating Center and Expert Advisory Panel

smokers at the time of diagnosis. 5 Although compelling data have shown that quitting smoking after a cancer diagnosis leads to better health and quality of life outcomes, a 2009 survey reported that only 38% of NCI Cancer Centers recorded smoking as a

Full access

CLO24-057: Characterization of Short-Term Surgical Outcomes in Laparoscopic Gastrectomy at a High-Volume Center in Latin America: 10 Years of Experience

Gloria Florez, Jorge Isaac Vargas, Liliana María Suárez Olarte, German Jimenez, Raúl Enrique Guevara, Wilmar Martin, Nicolás Felipe Camargo, Eduardo Espin Lanz, and Francisco Solano Perdomo

laparoscopic approach, including reduced bleeding, postoperative recovery, and complications, without compromising oncological outcomes, have been extensively described. Methods: A retrospective observational study of patients who underwent laparoscopic

Full access

CLO22-035: Treatment Outcome of Ruxolitinib and Decitabine Combination Chemotherapy Among Transplant Ineligible Advanced Stage Myeloproliferative Neoplasm: A Meta-analysis

Jacqueline Agustin and Ma. Rosario Irene D. Castillo

not eligible for transplant, hence chemotherapy is a frequently chosen alternative. This meta-analysis sheds light on treatment outcomes of advanced stage myeloproliferative neoplasm patients treated with combination decitabine and ruxolitinib

Full access

NCCN Guidelines Updates: Discontinuing TKI Therapy in the Treatment of Chronic Myeloid Leukemia

Neil P. Shah

response levels on outcome. Findings showed that no significant difference was observed for relapse according to depth of molecular response at discontinuation. Data from Mahon et al. 2 Relaxing the threshold, as well as the duration of DMR, has made TKI